- Home
- ABTS vs RSLS Comparison
ABTS vs RSLS Comparison
Compare ABTS & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- RSLS
- Stock Information
- Founded
- ABTS 2010
- RSLS 2002
- Country
- ABTS Hong Kong
- RSLS United States
- Employees
- ABTS N/A
- RSLS N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- RSLS Medical/Dental Instruments
- Sector
- ABTS Technology
- RSLS Health Care
- Exchange
- ABTS Nasdaq
- RSLS Nasdaq
- Market Cap
- ABTS 4.6M
- RSLS 4.5M
- IPO Year
- ABTS N/A
- RSLS 2007
- Fundamental
- Price
- ABTS $4.77
- RSLS $4.18
- Analyst Decision
- ABTS
- RSLS Hold
- Analyst Count
- ABTS 0
- RSLS 1
- Target Price
- ABTS N/A
- RSLS N/A
- AVG Volume (30 Days)
- ABTS 397.7K
- RSLS 3.1M
- Earning Date
- ABTS 04-30-2025
- RSLS 05-21-2025
- Dividend Yield
- ABTS N/A
- RSLS N/A
- EPS Growth
- ABTS N/A
- RSLS N/A
- EPS
- ABTS N/A
- RSLS N/A
- Revenue
- ABTS $6,711,225.00
- RSLS $7,175,000.00
- Revenue This Year
- ABTS N/A
- RSLS $52.80
- Revenue Next Year
- ABTS N/A
- RSLS N/A
- P/E Ratio
- ABTS N/A
- RSLS N/A
- Revenue Growth
- ABTS 299.11
- RSLS N/A
- 52 Week Low
- ABTS $1.35
- RSLS $4.03
- 52 Week High
- ABTS $14.10
- RSLS $414.99
- Technical
- Relative Strength Index (RSI)
- ABTS 59.34
- RSLS 38.80
- Support Level
- ABTS $3.75
- RSLS $4.03
- Resistance Level
- ABTS $4.40
- RSLS $8.29
- Average True Range (ATR)
- ABTS 0.53
- RSLS 0.77
- MACD
- ABTS 0.01
- RSLS 0.24
- Stochastic Oscillator
- ABTS 100.00
- RSLS 3.52
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.